h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
UOMi006-A
Registration Summary
:
A
P
E
C
AKLCS-hiPSC-PT6
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
UOMi006-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
UOMi006-A (RRID:CVCL_A7IN)
Alternative name(s)
AKLCS-hiPSC-PT6
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
23rd April 2021
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
University of Manitoba (UOM)
External Databases
Cellosaurus
CVCL_A7IN
Wikidata
Q107117352
General Information
Publications
Lester Sequiera G et al. Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome. Cells. 2021 Mar 5;10(3).
Srivastava A et al. Human induced pluripotent stem cell (hiPSC) line UOMi006-A derived from PBMCs of a patient with Kearns-Sayre syndrome. Stem cell research. 2021 May;53:102355.
Srivastava A et al. Establishment of a new human iPSC cell line (UOMi007-A) from a patient with Hypophosphatasia. Stem cell research. 2022 Aug;63:102839.
Adelipour M et al. The role of autophagy in the metabolism and differentiation of stem cells. Biochimica et biophysica acta. Molecular basis of disease. 2022 Aug 1;1868(8):166412.
Srivastava A et al. Reprogramming of Hypophosphatasia patient cells to generate a new human iPSC cell line (UOMi009-A). Stem cell research. 2022 Oct;64:102921.
Srivastava A et al. Generation of new human iPSC cell line (UOMi008-A) from a Hypophosphatasia patient. Stem cell research. 2022 Oct;64:102891.
Srivastava Abhay et al. iPSC-Based Disease Modeling and Functional Assessment of Neurons in Patients with Metabolic Disorder. Methods in Molecular Biology. 2024-00-00.
Sareen N et al. Establishment of a new human iPSC cell line (UOMi012-A) from a patient with congenital heart defect who has undergone Fontan procedure. Stem cell research. 2024 Oct;80:103509.
* Is the cell line readily obtainable for third parties?
No
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.